Macrocycles in Drug Discovery
Jeremy Levin
2014 ඔක් · Drug Discovery Series පොත 40 · Royal Society of Chemistry
ඉ-පොත
528
පිටු
reportඇගයීම් සහ සමාලෝචන සත්‍යාපනය කර නැත වැඩිදුර දැන ගන්න
මෙම ඉ-පොත ගැන
This book reviews macrocycles in drug discovery, both those of natural origin and semi-synthetic derivatives of natural products, and those designed and synthesized based on principles of medicinal chemistry.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.
කර්තෘ පිළිබඳ
Jeremy Levin is currently a Director of Medicinal Chemistry at Boehringer Ingelheim Pharmaceuticals, with a total of 25 years of experience in the pharmaceutical industry. He has worked in multiple therapeutic areas, including CNS, inflammation and immunology, and oncology. Dr Levin has authored or co-authored more than 70 papers in peer reviewed journals and served as an inventor on more than 60 issued U.S patents.
මෙම ඉ-පොත අගයන්න
ඔබ සිතන දෙය අපට කියන්න.
කියවීමේ තොරතුරු
ස්මාර්ට් දුරකථන සහ ටැබ්ලට්
Android සහ iPad/iPhone සඳහා Google Play පොත් යෙදුම ස්ථාපනය කරන්න. එය ඔබේ ගිණුම සමඟ ස්වයංක්‍රීයව සමමුහුර්ත කරන අතර ඔබට ඕනෑම තැනක සිට සබැඳිව හෝ නොබැඳිව කියවීමට ඉඩ සලසයි.
ලැප්ටොප් සහ පරිගණක
ඔබට ඔබේ පරිගණකයේ වෙබ් බ්‍රව්සරය භාවිතයෙන් Google Play මත මිලදී ගත් ශ්‍රව්‍යපොත්වලට සවන් දිය හැක.
eReaders සහ වෙනත් උපාංග
Kobo eReaders වැනි e-ink උපාංග පිළිබඳ කියවීමට, ඔබ විසින් ගොනුවක් බාගෙන ඔබේ උපාංගයට එය මාරු කිරීම සිදු කළ යුතු වේ. ආධාරකරු ඉ-කියවනයට ගොනු මාරු කිරීමට විස්තරාත්මක උදවු මධ්‍යස්ථාන උපදෙස් අනුගමනය කරන්න.
